InvestorsHub Logo

Dieselpro

04/22/21 1:55 PM

#160805 RE: Itchy palm #160801

There might be a couple cash pay people that don't mind spending $10,000 but as for medical insurance companies they will require the doctor to try the lesser expensive more effective Leronlimab before they approve spending that type of money for a patient that's not even in critical condition.

DonDonDonDon

04/22/21 2:09 PM

#160810 RE: Itchy palm #160801

$10,000 a patient WOW guess they won’t be using that in Philippines or Brazil and South America’s other poor countries


Correct. Poor countries are not going to dedicate a lot of resources to purchasing expensive monoclonal antibodies and that includes leronlimab. It is an unfortunate reality.